Literature DB >> 17656589

Psychological implications of Graves' orbitopathy.

I Coulter1, S Frewin, G E Krassas, P Perros.   

Abstract

Patients with thyroid eye disease, Graves' orbitopathy (GO), often appear distressed and it is likely that features of the condition such as disturbances in visual function, orbital discomfort and alterations in facial appearance can impart significant psychological morbidity upon the patient, which in turn can be detrimental to their quality of life. When considering the psychological impact of GO, two elements of the disease are important. The disfiguring changes to the eyes and face can have a direct effect upon psychological health, while physical aspects of the disease such as altered visual acuity, diplopia, orbital pain and lacrimation may influence psychological function as a secondary phenomenon, due to interference with daily living. Evidence appears to confirm the anecdotal impression of many clinicians dealing with GO patients that the prevalence of psychological morbidity in this patient group is high. A 'biopsychosocial' approach to care that addresses biological and psychosocial functioning as major determinants of health is an appropriate strategy when treating patients with GO.

Entities:  

Mesh:

Year:  2007        PMID: 17656589     DOI: 10.1530/EJE-07-0205

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  24 in total

1.  Orbital decompression for Graves' orbitopathy in England.

Authors:  P Perros; T Chandler; C M Dayan; A J Dickinson; P Foley; J Hickey; C J Macewen; J H Lazarus; J McLaren; G E Rose; J M Uddin; B Vaidya
Journal:  Eye (Lond)       Date:  2011-12-09       Impact factor: 3.775

Review 2.  Graves orbitopathy: a perspective.

Authors:  Petros Perros; Gerasimos E Krassas
Journal:  Nat Rev Endocrinol       Date:  2009-06       Impact factor: 43.330

3.  Measuring quality of life in oculoplastic patients.

Authors:  Edward Ridyard; Clare Inkster
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

4.  Neuroanatomic Variations in Graves' Dysthyroid Ophthalmopathy as Studied With MRI.

Authors:  Rona Z Silkiss; Alex R Wade
Journal:  Trans Am Ophthalmol Soc       Date:  2017-05-24

5.  Reduced cortical complexity in patients with thyroid-associated ophthalmopathy.

Authors:  Jiang Zhou; Wen Chen; Qian Wu; Lu Chen; Huan-Huan Chen; Hu Liu; Xiao-Quan Xu; Fei-Yun Wu; Hao Hu
Journal:  Brain Imaging Behav       Date:  2022-07-12       Impact factor: 3.224

6.  Does thyroid surgery for Graves' disease improve health-related quality of life?

Authors:  Gregorio Scerrino; Giuditta Morfino; Nunzia Cinzia Paladino; Valentina Di Paola; Emanuele Amodio; Gaspare Gulotta; Sebastiano Bonventre
Journal:  Surg Today       Date:  2012-12-11       Impact factor: 2.549

7.  Graves opthalmopathy and psychoendocrinopathies.

Authors:  Asaad A Ghanem; Mostafa A Amr; Lamiaa F Araafa
Journal:  Middle East Afr J Ophthalmol       Date:  2010-04

8.  Pathogenesis of thyroid-associated ophthalmopathy: does autoimmunity against calsequestrin and collagen XIII play a role?

Authors:  Hooshang Lahooti; Kishan R Parmar; Jack R Wall
Journal:  Clin Ophthalmol       Date:  2010-05-14

9.  Quality of life and occupational disability in endocrine orbitopathy.

Authors:  Katharina A Ponto; Susanne Pitz; Norbert Pfeiffer; Gerhard Hommel; Matthias M Weber; George J Kahaly
Journal:  Dtsch Arztebl Int       Date:  2009-04-24       Impact factor: 5.594

10.  Disrupted Spontaneous Neural Activity in Patients With Thyroid-Associated Ophthalmopathy: A Resting-State fMRI Study Using Amplitude of Low-Frequency Fluctuation.

Authors:  Wen Chen; Qian Wu; Lu Chen; Jiang Zhou; Huan-Huan Chen; Xiao-Quan Xu; Hao Hu; Fei-Yun Wu
Journal:  Front Hum Neurosci       Date:  2021-06-11       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.